Breaking Breakthrough: Dr. Jitendra Sequences 10,000 TB Strains, Unveiling Secrets of Tuberculosis Escape
Tuberculosis: India Witnesses Breakthrough in Fight Against Deadly Disease, Completes Genome Sequencing of 10,000 M. tuberculosis Isolates
India has made a significant stride in the fight against tuberculosis, completing the genome sequencing of 10,000 isolates of “Mycobacterium tuberculosis” on the occasion of World TB Day. The achievement represents a major milestone in the country’s commitment to eradicating TB, five years ahead of the World Health Organization’s (WHO) 2030 targets.
Union Minister Dr. Jitendra Singh, addressing a summit in New Delhi’s Vigyan Bhawan, emphasized the government’s ambition to eliminate tuberculosis, highlighting the importance of collaborative research and the need for a whole-of-science, whole-of-government, and whole-of-mission approach to achieve this goal. The genome sequencing initiative is part of the Dare2eraD TB program, launched in March 2022, which focuses on data-driven research to eradicate TB.
The program, Indian Tuberculosis Genomic Surveillance (InTGS), is a collaborative effort between the Department of Biotechnology (DBT), the Council of Scientific and Industrial Research (CSIR), and the Indian Council of Medical Research (ICMR) with major clinical institutions. The program aims to sequence over 32,000 TB isolates to identify drug resistance mutations and improve treatment outcomes.
Dr. Jitendra Singh emphasized that the deep genomic dataset being developed has the potential to revolutionize TB diagnostics and drug resistance prediction. Genome sequencing can significantly improve diagnostic accuracy, enabling faster resistance profiling and reducing the time needed to determine effective treatments from weeks to mere hours or days. This will help tailor treatment regimens to individual patient needs, reducing the risk of treatment failure or relapse.
Dr. Jitendra Singh also highlighted the historical challenges of TB treatment in India, from the stigma surrounding the disease to the evolution of medical advancements. He stressed the need for greater community engagement, as eradication is not just a scientific or medical challenge but a societal one. “Unless we involve common people, raise their consciousness, and evoke their participation, our fight against TB will remain incomplete,” he said.
The completion of 10,000 genome sequences marks a significant achievement, hailed by DBT Secretary Dr. Rajesh Gokhale as a milestone. The data will be instrumental in strengthening India’s TB surveillance and diagnostic capabilities, with the goal of translating research into practical applications for real-world impact.
The event was attended by senior officials, including Dr. N. Kalaiselvi, Director General CSIR; Dr. Rajiv Bahl, Director General ICMR; and Dr. M. Srinivas, Director AIIMS, among others.
Original Source: https://www.dailyexcelsior.com/dr-jitendra-announces-genome-sequencing-of-10000-mycobacterium-tuberculosis-isolates-2/
Category :
Tags:
Publish Date: 2025-03-25 05:43:00
